ArticleBMC rheumatology2025
Autoimmune aplastic anemia- a rare and devastating presentation of Systemic Lupus Erythematosus - a case report.
Article in BMC rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSystemic lupus Erythematous (SLE) with its multisystem manifestations can sometimes throw the treating team into scientific oblivion. Bone marrow suppression increases the susceptibility to infection and life-threatening bleeding manifestations and hence timely diagnosis and treatment can be lifesaving in these patients. CASE PRESENTATION: Here we report such a young case of SLE who presented with anasarca, polyarthritis and other musculoskeletal manifestations. She was initially managed with steroids along with the evaluation of subnephrotic proteinuria with renal biopsy. Thereafter the disease followed a treacherous course with new onset pancytopenia and worsening renal parameters. It heralded the development of petechiae over the body and gum bleeding. Pulse steroids with broad spectrum antimicrobials were started considering sepsis or autoimmune pancytopenia. Her blood counts worsened further. Bone marrow examination revealed autoimmune aplastic anemia while renal biopsy showed class IV nephritis. The patient was treated with intravenous immunoglobulins and cyclophosphamide. Subsequently, she responded to the therapy and her blood counts and renal function gradually improved. On follow up, anasarca has resolved completely with normal blood and renal parameters.
conclusionTimely aggressive therapy can save a life from such devastating conditions like autoimmune aplastic anemia. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.